Small molecule glucagon release inhibitors with activity in human islets

Overview of attention for article published in Frontiers in endocrinology, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 29,026 followers.

RT @DanielJDrucker: GLP-1R agonists, DPP-4 inhibitors and #insulin all inhibit glucagon secretion. Is there a therapeutic window for more p…

09 May 2023

Reply Repost Favourite

RT @DanielJDrucker: GLP-1R agonists, DPP-4 inhibitors and #insulin all inhibit glucagon secretion. Is there a therapeutic window for more p…

09 May 2023

Reply Repost Favourite

RT @DanielJDrucker: GLP-1R agonists, DPP-4 inhibitors and #insulin all inhibit glucagon secretion. Is there a therapeutic window for more p…

09 May 2023

Reply Repost Favourite

GLP-1R agonists, DPP-4 inhibitors and #insulin all inhibit glucagon secretion. Is there a therapeutic window for more potent direct inhibitors of glucagon secretion #diabetes @FrontiersIn https://t.co/7f15wGRASJ

09 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.